News
SOPH
8.43
+1.08%
0.09
Weekly Report: what happened at SOPH last week (0914-0918)?
Weekly Report · 09/21 09:13
SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last?
NASDAQ · 09/18 10:48
SOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetization Inflect
Seeking Alpha · 09/16 14:33
Weekly Report: what happened at SOPH last week (0907-0911)?
Weekly Report · 09/14 09:13
Weekly Report: what happened at SOPH last week (0831-0904)?
Weekly Report · 09/07 09:12
Analysts Offer Insights on Healthcare Companies: SOPHiA GENETICS (SOPH) and COMPASS Pathways (CMPS)
TipRanks · 09/01 08:20
Weekly Report: what happened at SOPH last week (0824-0828)?
Weekly Report · 08/31 09:13
Weekly Report: what happened at SOPH last week (0817-0821)?
Weekly Report · 08/24 09:13
Biotech Stocks At 52-Week Highs - MRNA Surges +176% On Phase 3 Data, SCTV, MRVI, SOPH, IMNM
NASDAQ · 08/20 08:21
Tracking Al Gore's Generation Investment Management Portfolio - Q2 2026 Update
Seeking Alpha · 08/19 02:22
Weekly Report: what happened at SOPH last week (0810-0814)?
Weekly Report · 08/17 09:14
SOPHiA Genetics Earnings Call Highlights Growth Push
TipRanks · 08/17 00:09
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript
NASDAQ · 08/11 16:46
Weekly Report: what happened at SOPH last week (0803-0807)?
Weekly Report · 08/10 09:13
HC Wainwright & Co. Maintains Buy on Sophia Genetics, Raises Price Target to $14
Benzinga · 08/05 10:28
Sophia Genetics price target raised to $14 from $12 at H.C. Wainwright
TipRanks · 08/05 10:06
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $9
Benzinga · 08/05 10:05
Biotech Stocks At 52-Week Highs - UFPT +25%, INFU +33%, SOPH +20% On Q2 Reports, REPL, PBLS
NASDAQ · 08/05 08:09
SOPHiA GENETICS: Accelerating Platform Demand and Raised 2026 Revenue Outlook Underpin Daniel Brennan’s Buy Rating
TipRanks · 08/05 06:58
SOPHiA GENETICS (SOPH) Stock Jumps On Faster Growth And Higher Outlook
Simply Wall St · 08/05 00:33
More
Webull provides a variety of real-time SOPH stock news. You can receive the latest news about Sophia Genetics Sa through multiple platforms. This information may help you make smarter investment decisions.
About SOPH
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.